ALT (STOCKS)
Altimmune, Inc. Common Stock
$2.610000
+0.000000 (+0.00%)
Prev close: $2.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jerome B. Durso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $512.44M
- Employees
- 59
- P/E (TTM)
- -2.78
- P/B (TTM)
- 1.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.18 | $-0.25 | +0.0678 | +27.36% |
|
Dec 2025 (Q4)
|
$-0.27 | $-0.25 | -0.0249 | -10.16% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.28 | +0.0743 | +26.13% |
|
Jun 2025 (Q2)
|
$-0.27 | $-0.33 | +0.0562 | +17.23% |
Financial Statements
| Revenues | $36.00K |
| Nonoperating Income/Loss | $5.84M |
| Operating Expenses | $96.95M |
| Research and Development | $66.80M |
| Other Operating Expenses | $30.16M |
| Operating Income/Loss | -$96.92M |
| Income/Loss From Continuing Operations After Tax | -$91.08M |
| Income/Loss From Continuing Operations Before Tax | -$91.08M |
| Net Income/Loss | -$91.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$91.08M |
| Net Income/Loss Available To Common Stockholders, Basic | -$91.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.92 |
| Diluted Earnings Per Share | -$0.92 |
| Basic Average Shares | 301,262,945 |
| Diluted Average Shares | 301,262,945 |
| Assets | $335.63M |
| Current Assets | $334.68M |
| Noncurrent Assets | $954.00K |
| Fixed Assets | $208.00K |
| Other Non-current Assets | $746.00K |
| Liabilities | $51.64M |
| Current Liabilities | $11.32M |
| Accounts Payable | $1.53M |
| Wages | $2.64M |
| Other Current Liabilities | $7.16M |
| Noncurrent Liabilities | $40.32M |
| Long-term Debt | $34.51M |
| Other Non-current Liabilities | $5.82M |
| Equity | $283.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $283.99M |
| Liabilities And Equity | $335.63M |
| Net Cash Flow From Operating Activities | -$71.64M |
| Net Cash Flow From Operating Activities, Continuing | -$71.64M |
| Net Cash Flow From Investing Activities | -$131.06M |
| Net Cash Flow From Investing Activities, Continuing | -$131.06M |
| Net Cash Flow From Financing Activities | $251.20M |
| Net Cash Flow From Financing Activities, Continuing | $251.20M |
| Net Cash Flow | $48.50M |
| Net Cash Flow, Continuing | $48.50M |
| Comprehensive Income/Loss | -$91.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$91.27M |
| Other Comprehensive Income/Loss | -$19.20M |